• No results found

Pediatric Antibacterial and Antifungal Trials From 2007 to 2017

N/A
N/A
Protected

Academic year: 2020

Share "Pediatric Antibacterial and Antifungal Trials From 2007 to 2017"

Copied!
11
0
0

Loading.... (view fulltext now)

Full text

Figure

FIGURE 1Generation of pediatric antibacterial and antifungal drug trials with industry or US federal
TABLE 1  Number of Studies and Participants in Pediatric Antibacterial and Antifungal Drug Trials Stratified by Infection Type
TABLE 2  Number of Pediatric Antibacterial and Antifungal Drug Trials Stratified by Age, Enrollment, Size, Location, and Funding Source
FIGURE 2Duration of pediatric antibacterial and antifungal drug trials. A, Pediatric antibacterial and/or  antifungal drug trials stratified by the type of anti-infective compound
+2

References

Related documents

Abbott et al. [118], examined the hypothesis that palpable intersegmental hypermobility correlated with hypermobility revealed in lateral flexion-extension radiographic studies

Multifractal fluctuations in the time dynamics of geoelectrical data, recorded in a seismic area of southern Italy, have been revealed using the Multifractal Detrended

At baseline in comparison to healthy controls, it was hypothesized that CWP would demonstrate (1) affected (reduced or increased) connectivity within and between the DMN and SN, and

In November 2011, India's central government announced retail reforms for both multi-brand stores and single-brand stores.. These market reforms paved the way for

The frequency of airway obstruction using different spirometry prediction equations and diagnostic criteria including forced expiratory volume in 1 s (FEV1)/forced vital capacity

biofilm models have already been described on various mate- rial surfaces in order to investigate new antimicrobial strate- gies. However, only a few studies have evaluated titanium

We found that knockdown of lncRNA H19 can ameliorate tamoxifen resistance and promote cell apoptosis and inhibit cell prolif- eration in tamoxifen-resistant breast cancer

of BiPAP has been evaluated in acute settings as well: in acute exacerbation of COPD, its use leads to an increase of arterial oxygen partial pressure (PaO 2 ), a reduction